MS

Biogen Starts Patient Enrollment
Yahoo/Zacks.com
Wed, 05/26/10 - 11:11 am
Biogen Idec
Abbott Laboratories
Acorda Therapeutics
daclizumab
Avonex
MS
FDA extends review on Novartis oral MS drug by three months
Pharma Times, UK
Tue, 05/25/10 - 09:02 am
FDA
Novartis
MS
multiple sclerosis
Gilenia
FDA Rejects 2nd Teva Citizen Petition Against Generic Copaxone
WSJ Online
Thu, 05/13/10 - 10:38 am
FDA
generics
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva's Double-Edged Sword
Motley Fool
Wed, 05/5/10 - 09:20 pm
Teva Pharmaceuticals
MS
Copaxone
generics
Mirapex
Boehringer Ingelheim
Ratiopharm
Novartis Races to Be First With Oral MS Drug
Seeking Alpha
Mon, 04/19/10 - 10:57 am
Novartis
multiple sclerosis
MS
Biogen Idec
Merck
Genzyme's Dilemma: Its Cheap Cancer Drug Wants to Cannibalize a Potential MS Blockbuster
BNET Pharma
Fri, 04/16/10 - 11:16 am
Genzyme
cancer
MS
multiple sclerosis
Campath
Positive MS data may thwart Icahn's plans for Genzyme
Fierce Biotech
Thu, 04/15/10 - 09:58 am
MS
multiple sclerosis
Campath
Carl Icahn
Genzyme
Genzyme sees MS drug topping efficacy league
Reuters
Wed, 04/14/10 - 01:59 pm
Genzyme
Campath
multiple sclerosis
MS
Acorda’s Ampyra Runs Ahead of Other MS Treatments
Minyanville
Wed, 04/14/10 - 01:56 pm
MS
Acorda Therapeutics
AMPYRA
multiple sclerosis
Novartis moves closer to first oral MS treatment
Reuters
Tue, 04/13/10 - 09:58 am
Novartis
MS
multiple sclerosis
Gilenia
Biogen Races to Create Test for Brain Disease Linked to MS Drug
Bloomberg
Fri, 04/9/10 - 07:52 am
Biogen Idec
Tysabri
MS
multiple sclerosis
PML
Biogen, Merck, Bayer MS Drugs Targeted by Test Predicting Which Ones Work
Bloomberg
Mon, 03/29/10 - 10:09 am
Biogen Idec
Merck
Bayer
MS
multiple sclerosis
Acorda applies to extend Ampyra patent protection
Yahoo/AP
Mon, 03/22/10 - 09:54 am
Acorda Therapeutics
patents
AMPYRA
MS
multiple sclerosis
Biogen: Now 42 Cases Of Brain Infection In Tysabri Patients
WSJ Online
Thu, 03/18/10 - 07:28 am
Biogen Idec
Elan
Tysabri
MS
PML
Teva’s MS Treatment Copaxone Chalks Up 25% Sales Gain
WSJ Online
Wed, 02/17/10 - 09:01 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Teva, Active extend pact on oral MS therapy
Marketwatch
Mon, 02/8/10 - 11:37 am
Teva Pharmaceuticals
Active Biotech
partnerships
MS
multiple sclerosis
Acorda's MS Drug May Not Be the Windfall Investors Expect
Seeking Alpha
Wed, 01/27/10 - 10:57 am
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
Mon, 01/25/10 - 12:36 pm
MS
multiple sclerosis
Biogen Idec
FDA
AMPYRA
Novartis, Merck KGaA Pills Bring ‘New Horizon’ for MS
Bloomberg
Thu, 01/21/10 - 09:01 am
MS
multiple sclerosis
Novartis
Merck KGaA
Biogen Idec says Tysabri sales top $1 billion, new patients grow 30 percent
Yahoo/AP
Wed, 01/13/10 - 09:22 am
Biogen Idec
Tysabri
MS
multiple sclerosis

Pages